Though this does not appear to play a role in the maintenance of cetuximab resistance, since knockdown of IL6, IL6R, and IL6ST did not sensitize the cells to cetuximab, the respective contributions of intracellular and extracellular IL-6 in HNSCC may be a topic of further study. This evidence concerns the gene IL6ST and head and neck squamous cell carcinoma.